FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| QuVa Pharma, Inc. | 70092-100 | 70092-100-50 | Fentanyl PF 50 mcg/ml 55 ml- 60 ml syr | Fentanyl PF 50 mcg/ml 55 ml- 60 ml syr | 2750 ug/55 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-097 | 70092-097-43 | Fentanyl PF 50 mcg/ml 2ml- 3 ml syr | Fentanyl PF 50 mcg/ml 2ml- 3 ml syr | 100 ug/2 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-684 | 70092-684-48 | Fentanyl PF 50 mcg/ml 30 ml syr | Fentanyl PF 50 mcg/ml 30 ml syr | 1500 ug/30 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-099 | 70092-099-49 | Fentanyl PF 50 mcg/ml 30 ml- 35 ml MB | Fentanyl PF 50 mcg/ml 30 ml- 35 ml MB | 1500 ug/30 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-098 | 70092-098-44 | Fentanyl PF 50 mcg/ml 5 ml syr | Fentanyl PF 50 mcg/ml 5 ml syr | 250 ug/5 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-664 | 70092-664-74 | Fentanyl PF 50 mcg/ml 50 ml CADD FSFF | Fentanyl PF 50 mcg/ml 50 ml CADD FSFF | 2500 ug/50 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-509 | 70092-509-35 | Fentanyl PF 50 mcg/ml 50ml IVB | Fentanyl PF 50 mcg/ml 50ml IVB | 2500 ug/50 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-281 | 70092-281-08 | Hep 30,000 U add to 1000 ml NS bag | Hep 30,000 U add to 1000 ml NS bag | 30000 U/1000 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-217 | 70092-217-47 | Heparin 1 U/ml 20 ml NS syringe PF | Heparin 1 U/ml 20 ml NS syringe PF | 20 U/20 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-216 | 70092-216-50 | Heparin 1 U/ml 50 ml NS syr PF | Heparin 1 U/ml 50 ml NS syr PF | 50 U/50 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-112 | 70092-112-49 | Hydromorph PF 0.2 mg/ml 30ml NS-35 ml MB | Hydromorph PF 0.2 mg/ml 30ml NS-35 ml MB | 6 mg/30 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-114 | 70092-114-50 | Hydromorph PF 0.2 mg/ml 50ml NS syr | Hydromorph PF 0.2 mg/ml 50ml NS syr | 10 mg/50 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-115 | 70092-115-36 | Hydromorph PF 0.2 mg/ml in 100 ml NS IVB | Hydromorph PF 0.2 mg/ml in 100 ml NS IVB | 20 mg/100 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-111 | 70092-111-48 | Hydromorph PF 0.2 mg/ml in 30ml NS syr | Hydromorph PF 0.2 mg/ml in 30ml NS syr | 6 mg/30 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-287 | 70092-287-35 | Hydromorph PF 0.2 mg/ml in 50 ml NS IVB | Hydromorph PF 0.2 mg/ml in 50 ml NS IVB | 10 mg/50 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-686 | 70092-686-48 | Hydromorph PF 0.5 mg/ml 30 ml NS syr | Hydromorph PF 0.5 mg/ml 30 ml NS syr | 15 mg/30 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-290 | 70092-290-49 | Hydromorph PF 0.5 mg/ml 30ml NS-35 ml MB | Hydromorph PF 0.5 mg/ml 30ml NS-35 ml MB | 15 mg/30 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-405 | 70092-405-50 | Hydromorph PF 0.5mg/ml 50ml NS syr | Hydromorph PF 0.5mg/ml 50ml NS syr | 25 mg/50 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-687 | 70092-687-48 | Hydromorph PF 1 mg/ml 30 ml NS syr | Hydromorph PF 1 mg/ml 30 ml NS syr | 30 mg/30 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-118 | 70092-118-50 | Hydromorph PF 1 mg/ml 50 ml NS-60 ml syr | Hydromorph PF 1 mg/ml 50 ml NS-60 ml syr | 50 mg/50 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-294 | 70092-294-74 | Hydromorph PF 1 mg/ml 50ml NS CADD FSFF | Hydromorph PF 1 mg/ml 50ml NS CADD FSFF | 50 mg/50 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-546 | 70092-546-35 | Hydromorph PF 1 mg/ml in 50 ml NS IVB | Hydromorph PF 1 mg/ml in 50 ml NS IVB | 50 mg/50 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-116 | 70092-116-75 | Hydromorph PF0.2 mg/ml 100ml NS CADDFSFF | Hydromorph PF0.2 mg/ml 100ml NS CADDFSFF | 20 mg/100 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-293 | 70092-293-49 | Hydromorph PF1 mg/ml 30ml NS-35 ml MB SS | Hydromorph PF1 mg/ml 30ml NS-35 ml MB SS | 30 mg/30 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-286 | 70092-286-74 | HydromorphPF 0.2 mg/ml 50ml NSCADD-FSFF | HydromorphPF 0.2 mg/ml 50ml NSCADD-FSFF | 10 mg/50 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-147 | 70092-147-03 | KCl 10 mEq lido 10 mg add 100 ml NS bag | KCl 10 mEq lido 10 mg add 100 ml NS bag | 10 mg/100 mL; 10 meq/100 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-563 | 70092-563-43 | Ketamine 10 mg/ml in 2 ml NS- 3 ml syr | Ketamine 10 mg/ml in 2 ml NS- 3 ml syr | 20 mg/2 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-119 | 70092-119-44 | Ketamine 10 mg/ml in 5ml NS syr | Ketamine 10 mg/ml in 5ml NS syr | 50 mg/5 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-120 | 70092-120-43 | Ketamine 50 mg/ml 1 ml- 3 ml syr | Ketamine 50 mg/ml 1 ml- 3 ml syr | 50 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-612 | 70092-612-44 | L.E.T. Gel 1.5 ml in 3 ml Top Syr | L.E.T. Gel 1.5 ml in 3 ml Top Syr | 60 mg/1.5 mL; 7.5 mg/1.5 mL; .75 mg/1.5 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-611 | 70092-611-44 | L.E.T. Gel 3 ml in 5 ml TS | L.E.T. Gel 3 ml in 5 ml TS | 120 mg/3 mL; 15 mg/3 mL; 1.5 mg/3 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-658 | 70092-658-44 | L.E.T. Solution 3 ml in 5 ml TS | L.E.T. Solution 3 ml in 5 ml TS | 120 mg/3 mL; 15 mg/3 mL; 1.5 mg/3 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-009 | 70092-009-44 | Labetalol HCl PF 5 mg/ml 4 ml-5 ml syr | Labetalol HCl PF 5 mg/ml 4 ml-5 ml syr | 20 mg/4 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-443 | 70092-443-43 | Lido 1% Bicarb PF 1 ml-3 ml syr | Lido 1% Bicarb PF 1 ml-3 ml syr | 9.1 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-175 | 70092-175-46 | Lidocaine 1% Bicarb 10 ml syr PF | Lidocaine 1% Bicarb 10 ml syr PF | 91 mg/10 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-161 | 70092-161-43 | Methadone PF 1mg/ml in 1ml NS- 3ml syr | Methadone PF 1mg/ml in 1ml NS- 3ml syr | 1 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-310 | 70092-310-46 | Methohexital PF 100 mg (10 mg/ml) 10 ml in SWFI syringe | Methohexital PF 100 mg (10 mg/ml) 10 ml in SWFI syringe | 100 mg/10 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-418 | 70092-418-36 | Midazolam 1 mg/ml in 100ml NS IVB | Midazolam 1 mg/ml in 100ml NS IVB | 100 mg/100 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-177 | 70092-177-35 | Midazolam 1 mg/ml in 50ml NS IVB | Midazolam 1 mg/ml in 50ml NS IVB | 50 mg/50 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-523 | 70092-523-50 | Morphine 1 mg/ml 50 ml NS syr | Morphine 1 mg/ml 50 ml NS syr | 50 mg/50 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-132 | 70092-132-43 | Morphine PF 0.5 mg/ml 2 ml-3ml syr | Morphine PF 0.5 mg/ml 2 ml-3ml syr | 1 mg/2 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-518 | 70092-518-75 | Morphine PF 1 mg/ml 100 ml NS CADD FSFF | Morphine PF 1 mg/ml 100 ml NS CADD FSFF | 100 mg/100 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-133 | 70092-133-43 | Morphine PF 1 mg/ml 2 ml- 3 ml syr | Morphine PF 1 mg/ml 2 ml- 3 ml syr | 2 mg/2 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-521 | 70092-521-74 | Morphine PF 1 mg/ml 50 ml NS CADD FSFF | Morphine PF 1 mg/ml 50 ml NS CADD FSFF | 50 mg/50 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-517 | 70092-517-43 | Morphine PF 1 mg/ml in 1 ml NS- 3 ml syr | Morphine PF 1 mg/ml in 1 ml NS- 3 ml syr | 1 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-380 | 70092-380-36 | Morphine PF 1 mg/ml in 100 ml NS IVB | Morphine PF 1 mg/ml in 100 ml NS IVB | 100 mg/100 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-519 | 70092-519-48 | Morphine PF 1 mg/ml in 30 ml NS syr | Morphine PF 1 mg/ml in 30 ml NS syr | 30 mg/30 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-520 | 70092-520-49 | Morphine PF 1 mg/ml in 30ml NS- 35 ml MB | Morphine PF 1 mg/ml in 30ml NS- 35 ml MB | 30 mg/30 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-522 | 70092-522-35 | Morphine PF 1 mg/ml in 50 ml NS IVB | Morphine PF 1 mg/ml in 50 ml NS IVB | 50 mg/50 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-046 | 70092-046-46 | Phenylephrine 100 mcg/ml 10ml syr | Phenylephrine 100 mcg/ml 10ml syr | 1000 ug/10 mL | 2024-2 | valid | 2026-09-18 |